Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Fermin Person1, Sara C Meyer2, Helmut Hopfer1

  • 1Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Schönbeinstrasse 40, 4031, PathologyBasel, Switzerland.

Insights

Myeloproliferative neoplasms (MPN) are linked to kidney issues like diffuse glomerulosclerosis. This study highlights potential MPN-related renal changes, including thrombotic microangiopathy, for clinicians to consider.

Area of Science:

  • Nephrology
  • Hematology
  • Pathology

Background:

  • Myeloproliferative neoplasms (MPN) are hematological disorders characterized by increased proliferation of blood cell lines.
  • Renal manifestations in MPN patients are not well-characterized.
  • Understanding kidney involvement is crucial for comprehensive MPN patient care.

Purpose of the Study:

  • To morphologically assess renal involvement in patients with Philadelphia-negative MPN.
  • To identify histopathological patterns of kidney damage in a post-mortem cohort.
  • To investigate potential links between MPN and specific renal pathologies.

Main Methods:

  • Analysis of histomorphological findings in a post-mortem cohort of 57 MPN patients.
  • Inclusion of MPN subtypes: polycythemia vera, primary myelofibrosis, essential thrombocythemia, and CMML.
  • Exclusion of diabetic or hypertensive nephropathy; assessment for C4d staining and glomerulonephritis.

Main Results:

  • 12.2% of patients showed diffuse glomerulosclerosis unrelated to diabetes or hypertension.
  • Chronic thrombotic microangiopathy (TMA) was suggested by C4d staining in 4/7 cases with glomerulosclerosis.
  • Other findings included extramedullary hematopoiesis (8.8%), tumor involvement (7.0%), arteriolosclerosis (31.6%), and signs of shock (14.0%).

Conclusions:

  • A potential causal relationship exists between idiopathic diffuse glomerular sclerosis and MPN, possibly involving TMA.
  • The clinical significance and pathophysiology of these renal findings require further investigation.
  • Hematologists should be aware of the spectrum of renal findings in MPN patients.

Related Concept Videos